| D |
|
DAG Induces Ca2+ Influx through NCKX-TRPC Interaction, Independently of PKC Activity
|
| Trifiro' E, Di Renzo L, Mattiello T, Pulcinelli FM |
| |
|
Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels
|
| Nair SC, Sakthivel MSM, Mammen JJ, Singh S, Viswabandya A, Kavitha ML, Mathews V, Srivastava A |
| |
|
DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N
|
| Nováková IRO, van Haren B, Verbruggen H, Masereeuw R, Lavergne LM, Schoormans S, van Kraaij M, van Heerde WL |
| |
|
D-Dimer and Factor VIII Are Independent Risk Factors for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis
|
| Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G |
| |
|
D-Dimer and the Risk of Venous Thromboembolism in Medical Patients
|
| Togna A, Ageno W, Ferrari E, Donadini M, Romualdi E, Galli M, Venco A |
| |
|
D-Dimer Assay Used in the Diagnosis of Acute Venous Thromboembolism
|
| De Piano LPA, Rached RA, Cavalheiro-Filho C, Chamone DAF |
| |
|
D-Dimer But Not Residual Venous Obstruction is a Risk Factor for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis
|
| Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G |
| |
|
D-Dimer Measurement after Acute Ischemic Stroke Does Not Predict Long Term Outcome Events
|
| Ageno W, Finazzi S, Mera V, Romualdi E, Viviani L, Bossi A, Venco A |
| |
|
D-dimer Stability of Specimens Stored AT -20 and -70 DEGREES Celsius
|
| Garcia D, Libby E, Fabre A, Blacklock L, Crookston K |
| |
|
D-Dimer Test in Cancer Patients with Suspected Acute Pulmonary Embolism
|
| Di Nisio M, Sohne M, Kamphuisen PW, Büller HR |
| |
|
D-dimer-Induced Derangement of Endothelial Extracellular Matrix Partially Is Mediated by TSP-1-Dependent Activation of TGFbeta1
|
| Yevdokimova N, Lugovskij E, Komisarenko S |
| |
|
Decreased Anticoagulant Response to Recombinant Tissue Factor Pathway Inhibitor (TFPI) in Pooled Normal Plasma with IgG Fractions from Patients with Lupus Anticoagulant is Associated with Increased Thrombin Generation
|
| Liestøl S, Mowinckel M-C, Sandset PM, Wisløff F |
| |
|
Decreased Contribution of ADP and Thromboxane A2 to Aggregation Induced by Collagen in Platelets from Chediak-Higashi Syndrome Affected Cattle
|
| Katsuaki I, Naofumi H, Sachiko K, Masahiro I |
| |
|
Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease
|
| Navarro S, Zorio E, Medina P, Estellés A, Osa A, Palencia MA, Cubillo P, Aznar J, España F |
| |
|
Decreased Platelet Expression of MYL9 (Myosin Light Chain Regulatory Polypeptide) and Other Genes with Platelet Dysfunction and CBFA2 (AML1) Mutation: Insights From Platelet Expression Profiling
|
| Sun L, Gorospe JR, Hoffman EP, Rao AK |
| |
|
Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice
|
| Raife TJ, Erger RA, Wilson KM, Fernandez JA, Altenburg J, Kim H-S, Griffin JH, Maeda N, Lentz SR |
| |
|
Deep Venous Thrombosis in Patients with Acute Pulmonary Embolism: Prevalence, Risk Factors and Clinical Significance
|
| Girard P, Meyer G, Leroyer C, Parent F |
| |
|
Defibrotide and Oligotide, Two DNA-Based Drugs, Protect Human Microvascular Endothelial Cells against Chemotherapy-Induced Damage and Activation
|
| Eissner G, Iacobelli M, Andreesen R, Holler E |
| |
|
Deficiency of Matrix Metalloproteinase-2 (MMP-2) Impairs Platelet-Dependent Haemostasis in Mice
|
| Momi S, Falcinelli E, Ruggeri L, Libert C, Gresele P |
| |
|
Defining Subclinical Phenotypes for Venous Thromboembolism through Measurement of a Hypercoagulable State in Thrombophilic Families
|
| Wichers IM, Tanck MWT, Meijers JCM, Lisman T, Reitsma PH, Rosendaal FR, Büller HR, Middeldorp S |
| |
|
Defining the Interaction between Cleaved High Molecular Weight Kininogen (HKa) and Tropomyosin
|
| Qi X, Donat[etilde] F, Mazar AP, McCrae KR |
| |
|
Degradation of Cross-linked Fibrin by Plasmin Together with Granulocyte-elastase under Certain Clinical Conditions
|
| Matsuura S, Tanaka H, Matsuda M |
| |
|
Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching
|
| Galanakis DK, Neerman-Arbez M, Scheiner T, Henschen A, Hubbs-T D, Nagaswami S, Marchi R, Kudryk B, Weisel J |
| |
|
Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy
|
| Gonzalez-Conejero R, Iniesta JA, Martinez C, Montaner J, García-Barberá N, Vicente V, Corral J |
| |
|
Demonstration of Patient Ability to Maintain Long Term Competence Equivalent to Professionals, Utilizing the HemoSense® INRatio® System for Home INR Testing
|
| Jacobson A, Ruybalid L, McInerney M |
| |
|
Dendroaspin, a Disintegrin-Like Venom Protein, Inhibits the Protective Effect of Fibrinogen on the Apoptosis of A375 Cells
|
| Xia M, Lu D, Scully M, Kakkar V, Lu X |
| |
|
Dental Procedure Using Recombinant Activated Factor VII (Novo Seven) in 22 Patients with Platelet Function Disorder in Iran
|
| Baghaipour MR, Rastegar Lari G, Mash'hadi Rahimi B, Sadeghian K |
| |
|
Derivation and Validation of a Simple Standardized Clinical Score to Predict Pulmonary Embolism in Emergency Patients: The Revised Geneva Score
|
| Le Gal G, Righini M, Roy PM, Sanchez O, Cornuz J, Bounameaux H, Perrier A |
| |
|
Derivation of a Clinical Model to Predict the Likelihood of Recurrent Deep Vein Thrombosis
|
| Bates SM, Julian J, Kearon C, Kahn SR, Geerts W, Kovacs MJ, Crowther MA, Gerdes V, Ginsberg JS |
| |
|
Derivatives of Coenzyme A Inhibit Platelet Aggregation via Effects at P2Y1 and P2Y12 Receptors
|
| Heptinstall S, Tang S-W, Manolopoulos P, Fox SC, May JA, Glenn JR, Ralevic V |
| |
|
Design and Synthesis of Peptides Modified by Chromone and Azauacil – Inhibitors of Thrombin
|
| Poyarkov AA, Poyarkova' SA |
| |
|
Design of Small Molecular Weight Activation-specific GPIIb/IIIa Inhibitors Based on the CDR3 Region of a Phage Display-derived Single-chain Antibody
|
| Schwarz M, Rakenius A, Bassler N, Bode C, Peter K |
| |
|
Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia
|
| Czwalinna A, Lennemann K, Varvenne M, Wermes C, Eisert R, Priesack J, Ganser A, von Depka M |
| |
|
Detection of a Critical Degree of Platelet TxA2-Production Inhibition by the PFA100 in Aspirin-Treated Subjects: Possible Relevance for the Monitoring of Aspirin Resistance
|
| Leone M, Mezzasoma AM, Davì G, Gresele P |
| |
|
Detection of Activated Factor XII Associated with Blood Cells in Both FXII Normal and FXII Deficient Subjects
|
| Pritchard D, Polwart R, Craig D |
| |
|
Detection of Decreased GPIb Alpha Expression Using an Improved Flow Cytometric Assay in Pateints with an Inherited Macrothrombocytopenia and a Mild Clinical Phenotype
|
| Phillips SA, Couzens S, Giddings J, Collins P |
| |
|
Detection of Platelet Dense Granule Deficiency in Pediatric Patients by Quantitative Electron Microscopy
|
| Ye CC, Rand ML, Kahr WHA, Christensen H, Rosenberg HI, Edwards VD, Leung R, Blanchette VS, Abdelhaleem M |
| |
|
Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction
|
| Yamashita A, Sumi T, Goto S, Hoshiba Y, Nishihira K, Kawamoto R, Hatakeyama K, Date H, Imamura T, Ogawa H, Asada Y |
| |
|
Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients
|
| Baldi G, Altomonte F, Altomonte M, Ghirarduzzi A, Brusasco C, Parodi RC, Conti S, Iorio A |
| |
|
Determinants of Plaque Instability in Atherosclerotic Vascular Disease
|
| Rao DS, Fishbein MC |
| |
|
Determinants of Platelet Activation in Alzheimer's Disease
|
| Falco A, Davì G, Ciabattoni G, Porreca E, Di Febbo C, Di Iorio A, Paganelli R, Bucciarelli T, Pescara L, Del Re L, Giusti C, Sau A, Patrono C |
| |
|
Determinants of the Interindividual Variability in Response to Antiplatelet Drugs
|
|
| |
|
Determination of ADAMTS-13 Activity in 13 Patients with Ischemic Stroke
|
| Farías C, Kempfer A, Sanchez Luceros A, Amaral M, Vera E, Lazzari M |
| |
|
Determination of IgM Phosphatidylserine Dependent Antiprothrombin Antibodies Improves the Diagnostic Yield of Antiphospholipid Syndrome
|
| Atsumi T, Amengual O, Ieko M, Sakai Y, Yasuda S, Koike T |
| |
|
Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis
|
| Staelens S, Vanhoorelbeke K, Hadders M, Vauterin S, Platteau C, De Maeyer M, Huizinga E, Deckmyn H |
| |
|
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients
|
| Dworakowska D, Mikaszewski B, Lapinski M, Skibowska A, Stodulski D, Tomaszewski D, Dworakowski R, Stankiewicz C, Skokowski J, Czestochowska E |
| |
|
Determination of Platelet Activation Biomarkers Using the Surface Enhanced Laser Desorption/Ionisation Time of Flight (SELDI-TOF) Proteomic Approach
|
| Loof A, Camps S, Mathijssen NCJ, Verbruggen H, van Heerde WL |
| |
|
Determination of Platelet Derived Microparticles in Patients with Autoimmune Thrombocytopenia (AITP)
|
| Slavik L, Hlusi A, Krcova V, Pikalova Z |
| |
|
Determination of the Integrin Binding Properties of the Disintegrin-Like Loops of ADAM Proteins
|
| Lu D, Xia M, Scully M, Kakkar V, Chung F, Blobel C, Lu X |
| |
|
Determining a Functional Association Between the Integrin LFA-1 and the Volume Regulating Protein ICln in Lymphocytes
|
| Larkin D, Culligan KG, Tracey E, Freeley M, Long A, Moran N |
| |
|
Development and Clinical Evaluation of Two Chromogenic Substrate Methods For Monitoring Fondaparinux Sodium
|
| Klaeffling C, Dämgen-von Brevern G, Piechottka G, Mosch G, Mani H, Luxembourg B, Lindhoff-Last E |
| |
|
Development and Evaluation of an Automated Immunoassay for the Determination of D-Dimer on the Abbott AxSYM® Analyzer
|
| McCourt C, O'Kane K, Robertson S, Taylor V, Pritchard D |
| |
|
Development of a Bifunctional Inhibitor with Anticoagulant and Anti-Platelet Activity
|
| Lu X, Lu D, Goodwin C, Scully M, Kakkar V |
| |
|
Development of a High-throughput ELISA Assay to Study Platelet Function
|
| Salles I, Fontayne A, Deckmyn H |
| |
|
Development of a Latex Agglutination Test for the Measurement of Elastase-Digests of Fibrin in Plasma and Its Application to Clinical Samples
|
| Tanaka H, Nagahams Y, Sawai T, Sakurai G, Wada H, Ojiro M, Matsuda M |
| |
|
Development of a Mouse Serum Protein Map for Proteomic Research
|
| Moriarty R, Brennan M, Jackson CL, Cox D |
| |
|
Development of a New Test for the Global Fibrinolytic Capacity in Blood
|
| Rijken DC, Hoegee-de Nobel E, Jie AFH, Atsma DE, Nieuwenhuizen W |
| |
|
Development of ADP-coated Bead Columns for Ticlopidine Monitoring
|
| Satoh K, Kaneko M, Lu S, Jin W, Ozaki Y |
| |
|
Development of Antithrombotic Antibodies to Human Tissue Factor
|
| Meiring SM, Coetzee M |
| |
|
Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects
|
| Cornelli U, Maddineni J, Manoni M, Vana L, Hoppensteadt D, Florian-Kujawski M, Fareed J |
| |
|
Development of Non-pathogenic Antibodies to Platelet Factor 4 during Treatment by Fondaparinux after Hip Surgery
|
| Pouplard C, Couvret C, Regina S, Gruel Y |
| |
|
Development of Platelet Binding Sites for Factor Xa in A Platelet Subpopulation Responding to Synergistic Stimulation Requires Transglutaminase-catalyzed Serotonin Derivatization of Molecules Binding Through Serotonin and Integrin Receptors
|
| London FS |
| |
|
Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis
|
| Arey BJ, Youssef S, Hartl K, Stewart A, Crain E, Zaspel A, Bostwick J, Feyen JHM, Wong P, Schumacher W |
| |
|
Developmental Haemostasis and Response to Heparin Therapy in Children
|
| Monagle P, Ignjatovic V, Newall F, Furmedge J, Gan A, Summerhayes R, DeRosa L, Shann F, Butt W, Chan A |
| |
|
DG-Chrom AT: A New Commercial Antithrombin (AT) Assay (Anti-FXa)
|
| Zurbano MJ, Bono M, Martorell D |
| |
|
Diabetes Mellitus Does Not Increase Thrombogenicity of the Arterial Vessel Wall in Atherosclerotic LDLr-/- Mice
|
| Sommeijer D, Hauer A, Kuiper J, Reitsma P, Ten Cate H |
| |
|
Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors
|
| Mitsugu T, Yoshikazu Y, Yasunori S, Ri-ichiro K, Takaaki F, Mitsuho O, Shinji O, Makoto I, Mamoru H, Toshihiro O, Yoshihiko M, Katsuo S |
| |
|
Diagnosing and Treating Haemorrhagic Disorders in a Developing Country
|
| Devenish R, Sing H, Sarin E |
| |
|
Diagnosis and Treatment of Von Willebrand's Disease
|
| Lihacheva EA, Konyashina NI, Severova TV |
| |
|
Diagnosis of Acute Idiopathic Thrombotic Thrombocytopenic Purpura by Rapid Detection of ADAMTS 13 IgG Antibodies
|
| Kyrle PA, Scheiflinger F, Geiter S, Weltermann A, Vetr H, Knobl P, Eichinger S, Binder BR |
| |
|
Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography
|
| Thom K, Hanslik A, Haumer M, Albinni S, Greber S, Kitzmüller E, Salzer U, Male C |
| |
|
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer
|
| Toshihiko K, Hideo W, Tsutomu N, Yasunori A, Junji N, Satoshi O, Ken I, Norikazu Y, Takeshi N, Hiroshi S |
| |
|
Diagnostic Dilemma of a Patient with Strong Lupus Anticoagulant and Intramuscular Haemorrhage, Requiring Treatment with Recombinant FVIIa
|
| Low J, Joseph J, Exner T, Vickers C, Dodds A |
| |
|
Diagnostic Importance of C-Reactive Protein and D-Dimer in Critically Ill Patients
|
| Roitman E, Morozov Yu, Dementieva I |
| |
|
Diagnostic Management in Patients with Clinically Suspected Pulmonary Embolism with Clinical Decision Rule, Quantitative D-Dimer Test and Helical Computed Tomography – The Christopher Study
|
| Huisman MV |
| |
|
Diagnostic Strategy Using a Modified Clinical Decision Rule and D-Dimer Test to Rule Out Pulmonary Embolism in Elderly in- and Outpatients
|
| Söhne M, Kamphuisen PW, van MierloBüller PJWBHR |
| |
|
Diagnostic Value of D-Dimer Assay in Patients with Suspected Pulmonary Embolism: Results in a Multicentre Outcome Study, the ESSEP Study (Evaluation du Scanner Spiralé dans l'Embolie Pulmonaire)
|
| Parent F, Girard P, Meyer G, Leroyer C |
| |
|
Dietary Flavanols – Effects on Platelets and Leukocytes
|
| May JA, Zhao L, Heptinstall S |
| |
|
Dietary Vitamin B6 and Folate Intake is Inversely Related to Risk of Developing Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)
|
| Steffen LM, Cushman M, Jacobs DR, Rosamond W, Folsom AR |
| |
|
Differences between Patients’, Physicians’ and Pharmacists’ Preferences for Treatment Products in Hemophilia. A Discrete Choice Experiment
|
| Monzini MS, Gringeri A, Mannucci PM, Scalone L, Villa M, Mantovani LG |
| |
|
Differences in the Pathophysiologic Mechanisms of Rose Bengal Photochemical-Induced and FeCl3 Chemical-Induced Thrombosis Models in the Mouse
|
| Whinna HC |
| |
|
Differences in the VWF : Rico/VWF : Ag Ratios among Patients with Venous or Arterial Thromboses
|
| Golovina OG, Savina EI |
| |
|
Different Active Conformations Are Induced in the Collagen Receptor Integrin a2b1 by Outside Manipulation and Inside-out Signalling
|
| Van de Walle G, Schoolmeester A, Pareyn I, Vanhoorelbeke K, Deckmyn H |
| |
|
Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL)
|
| Scamardella F, Ghirarduzzi A, Albertazzi L, Pilia A, Accardo PA, Iotti M, Prampolini R, Brini M |
| |
|
Different Monitoring Methods for in Vitro and in Vivo Lepirudin, a Direct Thrombin Inhibitor: Diluted Thrombin Time (dTT), Activated Partial Thromboplastin Time (aPTT) and Ecarin Clotting Time (ECT)
|
| Salmela B, Ilveskero S, Syrjälä M, Lassila R |
| |
|
Different Patterns of Release of the Soluble Form of the Endothelial Protein C Receptor in Critically Ill Patients
|
| Camoin-Jau L, Leone M, Boutière-Albanèse B, Albanèse J, Martin C, Dignat-George F |
| |
|
Different Reactivity of Factor VIII Inhibitor in Congenital and Acquired Haemophilia A
|
| Pignoloni P, Bernasconi S, Santoro C, Mazzucconi MG |
| |
|
Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study
|
| Camporese G, Bernardi E, N'Tita K, Verlato F, Salmistraro G, Cordova R, Franz F, Simioni P, Prandoni P, Andreozzi GM |
| |
|
Different Vascular Response to endotoxin in Streptozotocin-Induced Diabetic Mice
|
|
| |
|
Differential Contribution of P2Y1 and P2Y12 ADP Receptors to GPVI-Mediated Phosphatidylserine Exposure on Platelets and Microparticles
|
| Appleby JA, Farndale RW, Goodall AH |
| |
|
Differential Digestion of LMWHs By Heparinase-I and Heparinase-II: Drug Developmental Implications
|
| Jeske WP, Maddineni J, Iqbal O, Hoppensteadt D, Fareed J |
| |
|
Differential Effects of a Glycoprotein Ib Binding Protein, Echiquatin, on Platelet Function in vitro and in vivo
|
| Huang TF, Lo PC |
| |
|
Differential Effects of Acidosis and Hypothermia on Clot Development in Swine
|
| Pusateri AE, Delgado AV, Martini WZ, Uscilowicz JM |
| |
|
Differential Impact of Selective Serotonin Reuptake Inhibitors on Platelet Activation
|
| Colucci G, Alberio L |
| |
|
Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin
|
| Florian-Kujawski M, Hoppensteadt D, Iqbal O, Cunanan J, Bick R, Wilmer M, Fareed J |
| |
|
Differential Regulation of Phosphorylation of Adapter Proteins Dok2 and Dok1 in Platelets
|
| Hughan SC, Watson SP |
| |
|
Differential Translocation of Syk, Akt, and Endothelial Nitric Oxide Synthase (eNOS) in Stimulated Platelets
|
| Blair P, Freedman JE, Sarkar S |
| |
|
Differential Upregulation of Tissue Factor and Tissue Factor Pathway Inhibitor in Monocytes by Activated Platelets and Lipopolysaccharide
|
| Appleby JA, Wright JR, Farndale RW, Goodall AH |
| |
|
Differential Value of Risk Factors and Clinical Signs for the Diagnosis of Pulmonary Embolism in Suspected Patients According to Age
|
| Le Gal G, Righini M, Perrier A, Bounameaux H |
| |
|
Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
|
| Madonna R, Li S, Lin L, Rajabi M, Wassler MJ, De Caterina R, Geng Y-J |
| |
|
Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
|
| Madonna R, De Caterina R, Willerson JT, Geng Y-J |
| |
|
Direct Flow Cytometry Counting of Circulating Endothelial Progenitor Cells in Whole Blood and Relationship with Cardiovascular Risk Factors
|
| Chironi G, Walch L, Levenson J, Simon A, Rendu F |
| |
|
Direct INR Determination by Use of Linear or Orthogonal Regression
|
| Merz M, Doerr H, Engelhardt W |
| |
|
Directing Thrombin
|
| Lane DA |
| |
|
Disabled-2 Is a Secreted Anti-adhesive Molecule During Platelet Activation and Aggregation
|
| Tseng CP, Huang CL, Liao CH, Cheng JC |
| |
|
Disclosure of Microdomain Structure and Function in Arterial Thrombi of Heterogeneous Composition
|
| Munnix ICA, Kuijpers MJE, Thomassen MCLGD, van der Meijden PEJ, oude Egbrink MGA, van Zandvoort MAMJ, Rosing J, Siljander PRM, Heemskerk JWM |
| |
|
Discovery of Angiogenesis Inhibition by Natural Products Derived from Garlic: Potential Anti-Cancer Benefits
|
| Mousa AS, Mousa SA |
| |
|
Discrepancies between the Overall Coagulation Potential (OCP) Assay and International Normalised Ratio (INR) in Warfarin-Treated Patients
|
| Morel-Kopp M-C, Curnow J, Aboud M, Coyle L, Ward CM |
| |
|
Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII
|
| Boekhorst J, Lap PAJ, Loof AH, Verbruggen HW, van Kraaij MGJ, Nováková IRO, van Heerde WL |
| |
|
Disruption of a Hydrophobic Cluster Surrounding Tyearosine-131 in the Native Conformation of Antithrombin III Activates it for Factor Xa Inhibition and Increases Its Affinity for Heparin
|
| Dela Cruz RG, Jairajpuri MA, Bock SC |
| |
|
Disruption of an Immunogenic Epitope in the FVIII C2 Domain Results in the Prevention of Anti-FVIII-C2 Inhibitor Formation in BALB/c-FVIIIKO Hemophilic Mice
|
| Rawle F, Labelle A, Davie E, Pratt K, Lillicrap D |
| |
|
Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
|
| Jackson DE, Lau LM, Goschnick M, Robb L, Wright MD, Wee JL |
| |
|
Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
|
| Jackson DE, Lau LM, Goschnick M, Robb L, Wright MD, Wee JL |
| |
|
Disseminated Intravascular Coagulation (DIC) in Medical Intensive Care Unit (ICU): Prevalence, Associated Conditions, and Prognostic Factors
|
| Angchaisuksiri P, Puavilai T, Atichartakarn V, Ratanasiri S |
| |
|
Distinct Roles for the Type I PI 3-Kinases, p110b and p110g, in ADP-Stimulated Platelet Activation
|
| Schoenwaelder SM, Mangin P, Maxwell M, Kauffenstein G, Gachet C, Jackson SP |
| |
|
Distinct Roles of Basic Residues within the Heparin-Binding Exosite of Factor IX in the Assembly of the Factor X-Activating Complex
|
| Fribourg C, Rohlena J, Lenting PJ, Mertens K |
| |
|
Distinct Signals in Procoagulant Adherent Platelets Compared to Aggregated Platelets
|
| Sundaresan P, Siljander PR-M, Farndale RW |
| |
|
Disulfide Bond-Stabilized Factor VIII Mutants Demonstrate Improved Potency in Whole Blood FVIII-Sensitive ROTEG Assay
|
| Radtke K-P, Griffin JH, Gale AJ |
| |
|
Divergent Patterns of Vascular Endothelial Growth Factor (VEGF) in Patients with Acute Leukemia
|
| Elbaz O, Aladle D, Elawady M, Waly M |
| |
|
Diverging Signaling Events Control the Pathway of GPVI Down-Regulation in vivo
|
| Rabie T, Schulte V, Lanza F, Watson S, Saito T, Nieswandt B |
| |
|
Diving and Decompression Have Significant Effect on the Activation of Fibrinolysis
|
| Radziwon P, Tomaszewski R, Boczkowska-Radziwon B, Smoktunowicz M, K[lstrok]oczko J |
| |
|
Do Detached Endothelial Cells and Microparticles Contribute to the Procoagulant Activity Observed in Hemolytic Uremic Syndrome?
|
| Nestoridi E, Kushak RI, Ingelfinger JR, Grabowski EF |
| |
|
Do We Need the Geometric Mean as the Mean Normal Value in INR Determination?
|
| Arkin C |
| |
|
Does a F XIII – Deficiency Induce a Bleeding Tendency?
|
| Eberl W, Schwarte S |
| |
|
Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE
|
| Tapson VF, Spyropoulos AC, Froehlich JB, Kakkar AK, Merli GJ, Monreal M, Pavanello R, Turpie AGG, FitzGerald G, Anderson Jr. FA |
| |
|
Does Human Semen Contain a Functional Haemostatic System? A Possible Role for Tissue Factor Pathway Inhibitor in Fertility through Semen Liquefaction
|
| Lwaleed B, Greenfield R, Birch B, Cooper A |
| |
|
Does Pycnogenol Intensify Efficacy of Acetylsalicylic Acid in the Inhibition of Platelet Function?
|
| Watala C, Golanski J, Muchova J, Luzak B, Rozalski M, Durackova Z |
| |
|
Does the PE Risk in Abdominal Cancer Reflect Location, Spread or Tumour Type? Observations from a Population-Based Autopsy Study
|
| Ögren M, Wernevik L, Wåhlander K, Eriksson H, Bergqvist D, Sternby NH |
| |
|
Does Type 1 VWD Exist
|
| Peake IR |
| |
|
Domain A1 in Unfolded von Willebrand Factor Can Recruit Flowing Platelets to Collagen Surfaces Independently of Domain A3
|
| Bonnefoy A, Romijn RAP, Vandervoort PAH, Yamamoto H, Vermylen J, Hoylaerts MF |
| |
|
Dose-Dependent And Differential Effects of Two Doses of Continuous Combined Hormone Replacement Therapy (HRT), Tibolone And Raloxifene on Markers of Coagulation Activation
|
| Eilertsen AL, Qvigstad E, Andersen TO, Mowinckel M-C, Sandvik L, Sandset PM |
| |
|
Dose-Dependent Clopidogrel-Atorvastatin Drug–Drug Interaction Determined by Light Transmission Aggregometry
|
| Lau W, Carville D, Guyer K, Neer C, Bates E |
| |
|
Dose-dependent Platelet Activation and Microparticle Release by Different Clinical Antithymocyte Globulins
|
| Trummer A, De Rop C, Depka M, von, Hertenstein B |
| |
|
Dose-Related Inhibition of Factor Xa in Healthy Subjects by Razaxaban, an Orally-Active Selective Factor Xa Inhibitor
|
| Mosqueda-Garcia R, Knabb R, Frost C, Kornhauser D |
| |
|
Dosing Regimen of rFVIIa for Orthopedic Surgery in Hemophilia with Inhibitor – What Is the Right Dose?
|
| Chan AKC |
| |
|
Downregulation of Angiogenesis by DNAzymes to b1 mRNA Integrin Subunit
|
| Niewiarowska J, Sacewicz I, Wiktorska M, Papiewska I, Walczewska A, Okruszek A, Cierniewski CS |
| |
|
Down-Regulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate in Primates
|
| Raake W, Hoppensteadt D, Schultz C, Neville B, Fareed J |
| |
|
Down-regulation of Low-Density Lipoprotein-induced Platelet Signaling
|
| Korporaal SJA, Bezemer M, Gorter G, Akkerman JWN |
| |
|
Down-regulation of Tissue Factor Surface Expression by Annexin A5: a New Anticoagulant Mechanism
|
| Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L, Reutelingsperger C |
| |
|
Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo
|
| Hoffmann U, Brueckmann M, Wiessner M, Kettenmann E, Liebetrau C, Lang S, Borggrefe M, Huhle G |
| |
|
Drug Induced Changes in Fibrin Clot Permeability in Patients with Coronary Artery Disease
|
| Celinska-Lowenhoff M, Lowenhoff T, Undas U, Szczeklik A |
| |
|
Drug induced inhibition of platelet function and immune hemolytic anemia (CASE REPORT)
|
| Ioannidis G, Girtovitis F, Spartali A, Pithara E, Makris PE |
| |
|
Drug-induced Thrombocytopenia: Mapping of the binding Site of the Rifampicin-dependent Antibody on GPIX
|
| Chong BH, Zohra A, Shen MJ, Kroll H |
| |
|
Drugs with Anti-Prion Activity in Cell Culture Have Variable Effects on the Stimulation of Plasmin Generation by the Prion Protein NH2-terminal Fragment PrP23-110
|
| Praus M, Epple G, Gessner R, Ziemer S |
| |
|
Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
|
| Taliani MR, Becattini C, Agnelli G, Prandoni P, Moia M, Ageno W, Bazzan M, Salvi R, Guazzaloca G, Silingardi M, Poggio R, Bertoldi A, Imberti D, Ria L, Pogliani E, Ambrosio GB |
| |
|
Dynamic Imaging of Pericellular Proteolysis and Collagen Remodeling in Live-Cell Systems
|
|
| |
|
Dynamic Responsiveness to Aspirin in Patients Undergoing PCI
|
| Varon D, Brill A, Abdelrahman N, Touretsky N, Mosseri E, Lotan H, Pugatch T, Mosseri M |
| |
